The ASA’s mission is to direct funding to research programs in both industry and academia where innovative, leading edge brain-based research is being done. Clinical biomedical research, behavioral research, and translational and population-based research has the greatest potential to break new ground in understanding Schizophrenia spectrum diseases, and discovering new approaches to prevent and CURE them. The model employed in funding research is aimed at optimizing results by fielding comprehensive efforts to move toward achieving a CURE through multidisciplinary investigator initiated research. Work in molecular and supramolecular chemistry, cognitive function, and study of brain injury & abnormality are prime real estate.
To promote progress in our goal of a CURE through cooperative endeavors with industry and academia, after an objective external review ensures that a proposed line of research is worthy of funding, we have the ability to fund longer-term studies that some other foundations may not commit to undertaking. We are mindful of the pressing need for a CURE, but are careful not to underestimate the value of longer term projects as a result of focusing on short-term results. Also integral to the overall research effort, is to foster the sharing of information and published dissemination of study results to industry and academia by ensuring that each research program funded is completed, and that its findings are published. Sharing research findings with the private research and academic communities effectively maximizes research productivity, by enabling researchers to cross-pollinate ideas, and potentially avoid wasteful duplication of effort.
Bio-medical research into the mechanisms of normal brain function at the behavioral, systems, and molecular levels is viewed as the most promising path to finding the cause of, and a CURE for Schizophrenia at this time. Researchers working all over the world are eligible to submit research proposals for funding, and the ASA actively seeks out research opportunities worthy of financial support. While the ASA is a results oriented organization focused primarily on funding academic and private research in the USA, England, Canada, and Australia, there is no restriction on where a proposal may come from. We expect a solution to arrive in pieces, where one research finding leads to another, until a breakthrough occurs. Our commitment to supporting research efforts to crack the code of Schizophrenia represents our single-minded commitment to A CURE IN OUR LIFETIME. Commitment to success in this lone goal is our operational motive, and we can accept nothing less than victory and the unconditional surrender of this disease.